Biovista initiates project on adverse events profiling and drug repositioning.

January 5, 2007Announcements

Biovista began work today on one clinical candidate and one pre-clinical candidate on behalf of a major Cambridge, MA biotechnology company. The aim is to elucidate adverse events profiles and repositioning opportunities using Biovista’s proprietary development platform. By defining the adverse events profile, the design of the clinical trial and choice of specific compounds will … Read More

Systems Literature Analysis paper in Pharmacogenomics journal

September 28, 2004Announcements

A Special Report in the October 2004 issue of the journal Pharmacogenomics is dedicated to Systems Literature Analysis and how this can be supported by Biovista’s BioLab Experiment Assistant tool. Abstract Systems literature analysis (SLA) is the literature-driven version of systems biology. It treats collections of scientific literature as a system of millions of interconnections … Read More

Biovista releases Journal Research Analyst tool

May 20, 2003Announcements

Biovista announced today the release of its new Corporate Intelligence tool Journal Research Analyst™. Journal Research Analyst™ (JRA) is a complete solution consisting of a manually curated database and a software application aimed at marketing and business development executives, researchers, competitive intelligence and strategic analysts. Driven by a database generated by extracting key information from … Read More

Biovista announces Systematic Innovation project

December 12, 2002Announcements

Biovista announced today the launch of a research project aimed at preparing a strategic roadmap in the area of systematic innovation and scientific discovery. The INNOVANET project is a multinational effort funded by the European Commission’s DG Information Society and aims to study the scientific discovery and innovation processes in order to define a roadmap … Read More

Biovista launches Literature-Based Discovery project

October 10, 2002Announcements

Biovista announced today the launch of an R&D project aimed at creating a literature-based discovery (LBD) tool to assist in early stage drug design. Launched as part of the work carried out within the Esperonto consortium, the project aims to develop core technologies required for the creation of an effective LBD system. The company will … Read More